Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New Cause of Diabetes

By Drug Discovery Trends Editor | February 18, 2016

In normal mice (top), the pancreas forms with normal spatial organization as seen by the distinct patterning of different colored cell types. In Pdx1 mutant mice (bottom), however, the pancreas is much smaller and loses its spatial organization. Scale bars = 50 micro meter. Source: Kawaguchi Laboratory, CiRA, Kyoto UniversityDiabetes describes a disease where the body is not receiving a sufficient supply of insulin. It commonly inflicts the pancreas, the organ responsible for insulin production. More specifically, it inflicts the cells that produce insulin, which are found in the endocrine tissue of the pancreas. However, new results from the Yoshiya Kawaguchi lab suggest the exocrine tissue, which is responsible for digestion, could have a role in treatment. “The pancreas is constituted of two tissues that are structurally and functionally distinct, which makes it unique”, said Prof. Yoshiya Kawaguchi of the Center for iPS Cell Research and Application, Kyoto University, which is why most researchers attend the endocrine tissue for diabetes.

However, while the exocrine and endocrine tissues operate independently in mature pancreas, they are formed at the same time during pancreas development. Kawaguchi wondered if diseased exocrine tissue could cause deficiencies in the production of endocrine cells. To investigate this possibility, his team constructed mice that depleted the Pdx1 gene, which in the pancreas is exclusively found in exocrine tissue. The result was underdeveloped pancreas, but in addition, and surprisingly, the mice showed diabetes phenotype, such as low insulin levels, suggesting endocrine development was also affected. However, what caught the researchers’ attention was which cells had changed. Endocrine progenitor cells that did not have the mutation in the mutant mice also showed poor survival. These results suggest non-cell autonomous effects, which describes the phenomenon where cells with genetic defects may cause malfunction in neighboring, genetically healthy cells, and could have important implications for diabetes treatment.

“This is an exciting finding”, explains Kawaguchi, adding, “It means the exocrine cells secrete something that promotes the differentiation and survival of endocrine cells during development”. This substance, Kawaguchi hopes, could lead to promising treatments for diabetes.

Source: Kyoto University


Filed Under: Drug Discovery

 

Related Articles Read More >

S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Drug companies sign “Most Favored Nation” deals, then raise prices anyway
New gonorrhea antibiotic could treat resistant infections
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE